Latest Shareholder Update, 1 Feb 08
...Welcome to this second edition of MTY News...
Positive Clinical Interim Results
...completed its ‘first-in-human’ clinical trial...
Clinical collaboration agreement signed, 4 Jun 07
....for up to three GI indications....
Commencing Human Clinical Trials of Cuprindo™
...clinical trials of Cuprindo™ to determine its safety...
Sucessful Settlement of Dispute
...MTY successfully settled its dispute with The University of Sydney...
Feature Article - Australian Investor Magazine
...making dramatic moves with new CEO...


Medical Therapies Ltd
(MTY):

Phase 1 clinical collaboration agreement signed with the centre for digestive diseases.

Sydney, 4 June 2007:  Medical Therapies Limited, (ASX: MTY), announced today that it has signed a Heads of Agreement to collaborate with the Centre for Digestive Diseases (CDD), an international clinical organisation based in Sydney, for Phase I clinical trials of Cuprindo™, MTY’s lead drug candidate.  Cuprindo™ will be tested for safety and early efficacy in acute conditions in an open label clinical trial using topical formulations. 

To find out more Download_the_.pdf

© Medical Therapies
Privacy | Contact Us
Web design company
Medical Therapies Ltd   ABN 69 111 304 119   T: +61 2 9299 0311   E: info@medicaltherapies.com.au